NEXI — Neximmune Cashflow Statement
0.000.00%
- $0.00m
- -$2.42m
- 17
- 59
- 13
- 19
Annual cashflow statement for Neximmune, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -20.5 | -29.9 | -50.9 | -62.5 | -32.3 |
Depreciation | |||||
Non-Cash Items | 1.54 | 2.93 | 3.59 | 6.39 | 4.77 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.842 | -0.089 | 0.655 | 3.93 | -4.88 |
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Cash from Operating Activities | -19.4 | -26.4 | -45.8 | -51.2 | -31.4 |
Capital Expenditures | -1.25 | -0.865 | -2.35 | -1.26 | -0.049 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 10.7 | 1.09 | -51.5 | 51.6 | 0.004 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 9.42 | 0.222 | -53.8 | 50.3 | -0.044 |
Financing Cash Flow Items | — | -0.364 | -0.019 | 5.15 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 18.8 | 22.1 | 125 | 5.18 | 0 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 8.77 | -4.1 | 25.3 | 4.3 | -31.5 |